Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Annovis Bio Inc (ANVS)

Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 55,730
  • Shares Outstanding, K 19,486
  • Annual Sales, $ 0 K
  • Annual Income, $ -24,590 K
  • EBIT $ -25 M
  • EBITDA $ -25 M
  • 60-Month Beta 1.57
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.20

Options Overview Details

View History
  • Implied Volatility 254.67% ( -156.99%)
  • Historical Volatility 138.31%
  • IV Percentile 64%
  • IV Rank 16.05%
  • IV High 1,372.26% on 02/12/25
  • IV Low 41.03% on 09/27/24
  • Put/Call Vol Ratio 0.07
  • Today's Volume 62
  • Volume Avg (30-Day) 193
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 13,959
  • Open Int (30-Day) 13,531

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.36
  • Number of Estimates 1
  • High Estimate -0.36
  • Low Estimate -0.36
  • Prior Year -0.44
  • Growth Rate Est. (year over year) +18.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.05 +30.73%
on 06/27/25
3.18 -15.72%
on 06/24/25
-0.13 (-4.63%)
since 06/13/25
3-Month
1.19 +125.21%
on 04/17/25
3.48 -22.99%
on 06/04/25
+1.46 (+119.67%)
since 04/15/25
52-Week
1.11 +141.44%
on 04/09/25
13.91 -80.73%
on 07/16/24
-9.96 (-78.80%)
since 07/15/24

Most Recent Stories

More News
Annovis to Attend the AAIC 2025 with Four Poster Presentations

ANVS : 2.68 (-6.29%)
Annovis Announces NYSE Acceptance of Plan to Regain Listing Compliance

ANVS : 2.68 (-6.29%)
Annovis to Host Webinar and Live Q&A on June 24, 2025

ANVS : 2.68 (-6.29%)
Annovis Provides Corporate Updates and Reports First Quarter 2025 Financial Results

ANVS : 2.68 (-6.29%)
Annovis Bio Appoints Hui Liu as Director of Biostatistics

ANVS : 2.68 (-6.29%)
Annovis Bio, Inc. Receives Continued Listing Standard Notice From the NYSE

ANVS : 2.68 (-6.29%)
Annovis to Attend AD/PD™ 2025 with Extensive Scientific Program

ANVS : 2.68 (-6.29%)
Annovis Provides Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results

ANVS : 2.68 (-6.29%)
Annovis Bio (NYSE: ANVS) to Present at Alzheimer’s & Parkinson’s Drug Development Summit

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company focused on neurodegenerative diseases, will participate in the 13th Alzheimer’s & Parkinson’s Drug Development Summit from March...

ANVS : 2.68 (-6.29%)
Annovis Joins Experts at Drug Development Summit to Redefine Parkinson's Treatment

ANVS : 2.68 (-6.29%)

Business Summary

Annovis Bio Inc. is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease, Parkinson's disease and Alzheimer's in Down Syndrome. Annovis Bio Inc. is headquartered in Berwyn, Pennsylvania.

See More

Key Turning Points

3rd Resistance Point 3.13
2nd Resistance Point 3.03
1st Resistance Point 2.85
Last Price 2.68
1st Support Level 2.57
2nd Support Level 2.47
3rd Support Level 2.29

See More

52-Week High 13.91
Fibonacci 61.8% 9.02
Fibonacci 50% 7.51
Fibonacci 38.2% 6.00
Last Price 2.68
52-Week Low 1.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar